Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
Boysen Fynboe Ebert, Eva, McCulloch, Tine, Holmskov Hansen, Karin, Linnet, Hanne, Sorensen, Boe, Meldgaard, Peter
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2020)
Get full text
Journal Article
EGFR Gene Polymorphism Predicts Improved Outcome in Patients With EGFR Mutation-positive Non–small cell Lung Cancer Treated With Erlotinib
Winther-Larsen, Anne, Fynboe Ebert, Eva Boysen, Meldgaard, Peter, Sorensen, Boe Sandahl
Published in Clinical lung cancer (01.05.2019)
Published in Clinical lung cancer (01.05.2019)
Get full text
Journal Article
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer
Ebert, Eva Boysen Fynboe, McCulloch, Tine, Hansen, Karin Holmskov, Linnet, Hanne, Sorensen, Boe, Meldgaard, Peter
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2020)
Get full text
Journal Article
Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients
Hojbjerg, Johanne Andersen, Ebert, Eva Boysen Fynboe, Clement, Michelle Simone, Winther-Larsen, Anne, Meldgaard, Peter, Sorensen, Boe
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Get full text
Journal Article